Fabio Scirocchi | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Functional reprogramming of neutrophils within the brain tumor microenvironment by hypoxia-driven histone lactylation	CANCER DISCOVERY	2025
The Complexity of Malignant Glioma Treatment	CANCERS	2025
CD137+ and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line	JOURNAL OF TRANSLATIONAL MEDICINE	2024
Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma	IMMUNITY	2024
Exploring Genomic Biomarkers for Pembrolizumab Response: A Real-World Approach and Patient Similarity Network Analysis Reveal DNA Response and Repair Gene Mutations as a Signature	CANCERS	2024
Anti-PD1 therapies induce an early expansion of Ki67+CD8+ T cells in metastatic non-oncogene addicted NSCLC patients	FRONTIERS IN IMMUNOLOGY	2024
Circulating CD137+ T cell levels are correlated with response to pembrolizumab treatment in advanced head and neck cancer patients	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2023
Macrophage galactose-like lectin mediated interactions: investigating immunosuppressive mechanisms in glioblastoma	www.siica.it	2023
Targeting FGFRs by pemigatinib induces G1 phase cell cycle arrest, cellular stress and upregulation of tumor suppressor microRNAs	JOURNAL OF TRANSLATIONAL MEDICINE	2023
Circulating CD137+ T cell subsets and MDCSs as immune biomarkers for response to anti-PD1 immunotherapy in NSCLC patients	AICC INTERNATIONAL MEETING – TRANSLATIONAL AND PRECISION MEDICINE	2023
Circulating CD137 + T cells correlate with improved response to anti-PD1 immunotherapy in cancer patients	CLINICAL CANCER RESEARCH	2022
Immune effects of CDK4/6 inhibitors in patients with HR+/HER2− metastatic breast cancer: relief from immunosuppression is associated with clinical response	EBIOMEDICINE	2022
Glycan-Lectin Interactions as Novel Immunosuppression Drivers in Glioblastoma	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2022
Soluble PD-L1 as a prognostic factor for Immunotherapy treatment in solid tumors: Systematic review and Meta-Analysis	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2022
DNA damage response and repair (DDR) gene mutations as an alternative mechanism to generate high TMB in never smoker NSCLC patients	ANNALS OF ONCOLOGY	2022
The role of soluble LAG3 and soluble immune checkpoints profile in advanced head and neck cancer: a pilot study	JOURNAL OF PERSONALIZED MEDICINE	2021
Immunogenic cell death and immunomodulatory effects of cabozantinib	FRONTIERS IN ONCOLOGY	2021
Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC Patients	JOURNAL OF PERSONALIZED MEDICINE	2020
Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC Patients	JOURNAL OF PERSONALIZED MEDICINE	2020